![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif)
ertumaxomab A murine monoclonal antibody with two antigen-recognition sites: one for CD3, an antigen expressed on mature T cells, and one for HER-2-neu, a tumor-associated antigen that promotes tumor growth. Ertumaxomab attaches to CD3-expressing T cells and HER-2-neu-expressing tumor cells, selectively cross-linking tumor and immunologic cells which results in the recruitment of cytotoxic T cells to the T cell/tumor cell aggregate. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif) | anti-CD3 x anti-HER-2-neu bispecific monoclonal antibody MOAB anti-CD3 x anti-HER-2-neu | | ![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif) | Abbreviation: | ![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif) | CD3-HER2neu MOAB | | ![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081005070958im_/http://www.nci.nih.gov/images/spacer.gif) |